MHI, AstraZeneca Team on Genetic Analysis of CVD, Diabetes Markers | GenomeWeb

NEW YORK (GenomeWeb) – The Montreal Heart Institute and AstraZeneca will sift through tens of thousands of samples to hunt for genetic markers associated with cardiovascular disease and diabetes, MHI announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.